Bottai, G.; Diao, L.; Baggerly, K.A.; Paladini, L.; Győrffy, B.; Raschioni, C.; Pusztai, L.; Calin, G.A.; Santarpia, L.
Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 194.
https://doi.org/10.3390/ijms18010194
AMA Style
Bottai G, Diao L, Baggerly KA, Paladini L, Győrffy B, Raschioni C, Pusztai L, Calin GA, Santarpia L.
Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer. International Journal of Molecular Sciences. 2017; 18(1):194.
https://doi.org/10.3390/ijms18010194
Chicago/Turabian Style
Bottai, Giulia, Lixia Diao, Keith A. Baggerly, Laura Paladini, Balázs Győrffy, Carlotta Raschioni, Lajos Pusztai, George A. Calin, and Libero Santarpia.
2017. "Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer" International Journal of Molecular Sciences 18, no. 1: 194.
https://doi.org/10.3390/ijms18010194
APA Style
Bottai, G., Diao, L., Baggerly, K. A., Paladini, L., Győrffy, B., Raschioni, C., Pusztai, L., Calin, G. A., & Santarpia, L.
(2017). Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer. International Journal of Molecular Sciences, 18(1), 194.
https://doi.org/10.3390/ijms18010194
